Preclinical toxicity biomarkers for combination treatment with clotting factors rFXIII and rFVIIa

By Oleksiewicz M. B.   Schaal-Jensen R.   Kiehr B.   Krabbe J. Steenbuch   Sommer C.  

Biomarkers, Vol. 12, Iss. 4, 2007-07 ,pp. : 424-444

Informa Healthcare

Access to resources Recommend Favorite

Combination of sulfamethoxazole and selenium in anticancer therapy: a novel approach

By Gupta Ritu   Kazmi Imran   Afzal Muhammad   Khan Ruqaiyah   Chauhan Mohit   Al-Abbasi Fahad   Ahmad Aftab   Anwar Firoz  

Molecular and Cellular Biochemistry, Vol. 384, Iss. 1-2, 2013-12 ,pp. : 279-285

Springer Publishing Company

Access to resources Recommend Favorite

Synthetic Studies on Formamidopyrimidines Related to Clofarabine

By Cantrell William   Lovett Dennis   Engles Tracy   Anderson Bruce   Bauta William   Wolstenholme-Hogg Paul  

Nucleosides, Nucleotides & Nucleic Acids, Vol. 27, Iss. 8, 2008-08 ,pp. : 901-913

Taylor & Francis Ltd

Access to resources Recommend Favorite

Non-BRAF-targeted therapy, immunotherapy, and combination therapy for melanoma

By Tomei Sara   Wang Ena   Delogu Lucia Gemma   Marincola Francesco M   Bedognetti Davide  

Expert Opinion on Biological Therapy, Vol. 14, Iss. 5, 2014-05 ,pp. : 663-686

Informa Healthcare

Access to resources Recommend Favorite

Combination of Iron Overload Plus Ethanol and Ischemia Alone Give Rise to the Same Endogenous Free Iron Pool

By Sergent Odile   Tomasi Aldo   Ceccarelli Daniela   Masini Alberto   Nohl Hans   Cillard Pierre   Cillard Josiane   Vladimirov Yuri   Kozlov Andrey  

BioMetals, Vol. 18, Iss. 6, 2005-12 ,pp. : 567-575

Springer Publishing Company

Access to resources Recommend Favorite